Taken together, the effects of Akt-2 inhibition on both MYCN-amplified and non-MYCN amplified NB cells further supports the finding that SHMT2 affects both c-Myc and N-Myc protein expression via Akt-2. The gene discussed is SHMT2; the disease is neuroblastoma.